RxDoctor Payments Data

Antoinette Newman, MD

Hospice and Palliative Medicine · Columbia, MDNPI 1902338569

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.

$387in general payments, 2019–2025

Across 23 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Melinta Therapeutics, LLC$67
  • AstraZeneca$44
  • Mallinckrodt Hospital Products Inc.$39
  • GSK$34
  • Intercept Pharmaceuticals, Inc.$33
  • Baxter Healthcare$28
  • plus $141 from 8 others

What the payments were for

  • Food & beverage$387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$387 in reported general payments places this provider in the 60th percentile of 35 hospice and palliative medicine providers in Maryland.

See all hospice and palliative medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$52,588
Medicare patients
180
Services billed
456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl20$14,199
Morphine Sulfate12$1,192
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$1,129
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$1,005
Morphine Sulfate ErMorphine Sulfate30$910
Oxycodone Hcl35$861
Gabapentin37$578
Methadone Hcl22$234
Hydromorphone Hcl17$139
Lorazepam11$65
Zolpidem Tartrate14$38

Paid to pharmacies, not to this prescriber.

Other hospice and palliative medicine in Columbia

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →